FARALLON CAPITAL MANAGEMENT, L.L.C. Diversified Active

Location: San Francisco, CA

CIK: 0000909661 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value: $12.49B

Holdings (119)

IQV IQVIA HLDGS INC 4.3%
Value $539M Shares 3,796,030 Share Price $141.88 Est. Cost/Share — Unrealized @ Report Date —
FIS FIDELITY NATL INFORMATION SV 3.9%
Value $481M Shares 3,590,128 Share Price $134.09 Est. Cost/Share — Unrealized @ Report Date —
— IAC INTERACTIVECORP 3.6%
Value $456M Shares 1,410,000 Share Price $323.40 Est. Cost/Share — Unrealized @ Report Date —
CNC CENTENE CORP DEL 3.6%
Value $445M Shares 7,000,000 Share Price $63.55 Est. Cost/Share — Unrealized @ Report Date —
ABBV ABBVIE INC 3.3%
Value $407M Shares 4,150,000 Share Price $98.18 Est. Cost/Share — Unrealized @ Report Date —
TMO THERMO FISHER SCIENTIFIC INC 3.1%
Value $388M Shares 1,069,505 Share Price $362.34 Est. Cost/Share — Unrealized @ Report Date —
CHTR CHARTER COMMUNICATIONS INC N 3.1%
Value $385M Shares 755,015 Share Price $510.04 Est. Cost/Share — Unrealized @ Report Date —
TMUS T-MOBILE US INC 2.9%
Value $360M Shares 3,457,631 Share Price $104.15 Est. Cost/Share — Unrealized @ Report Date —
V VISA INC 2.8%
Value $348M Shares 1,799,373 Share Price $193.17 Est. Cost/Share — Unrealized @ Report Date —
AON AON PLC 2.7%
Value $331M Shares 1,720,498 Share Price $192.60 Est. Cost/Share — Unrealized @ Report Date —
ELV ANTHEM INC 2.6%
Value $329M Shares 1,250,000 Share Price $262.98 Est. Cost/Share — Unrealized @ Report Date —
GOOG ALPHABET INC 2.5%
Value $312M Shares 221,050 Share Price $1413.61 Est. Cost/Share — Unrealized @ Report Date —
MSFT MICROSOFT CORP 2.5%
Value $311M Shares 1,528,199 Share Price $203.51 Est. Cost/Share — Unrealized @ Report Date —
META FACEBOOK INC 2.5%
Value $308M Shares 1,358,494 Share Price $227.07 Est. Cost/Share — Unrealized @ Report Date —
— IHS MARKIT LTD 2.4%
Value $295M Shares 3,910,024 Share Price $75.50 Est. Cost/Share — Unrealized @ Report Date —
CRM SALESFORCE COM INC 2.3%
Value $286M Shares 1,525,648 Share Price $187.33 Est. Cost/Share — Unrealized @ Report Date —
— 58 COM INC 2.1%
Value $268M Shares 4,965,212 Share Price $53.94 Est. Cost/Share — Unrealized @ Report Date —
SHW SHERWIN WILLIAMS CO 2.1%
Value $259M Shares 447,987 Share Price $577.85 Est. Cost/Share — Unrealized @ Report Date —
WAB WABTEC 2.0%
Value $249M Shares 4,325,361 Share Price $57.57 Est. Cost/Share — Unrealized @ Report Date —
EXEL EXELIXIS INC 1.9%
Value $243M Shares 10,250,000 Share Price $23.74 Est. Cost/Share — Unrealized @ Report Date —
BMY BRISTOL-MYERS SQUIBB CO 1.7%
Value $213M Shares 3,625,000 Share Price $58.80 Est. Cost/Share — Unrealized @ Report Date —
— ACCELERON PHARMA INC 1.6%
Value $200M Shares 2,100,000 Share Price $95.27 Est. Cost/Share — Unrealized @ Report Date —
BABA ALIBABA GROUP HLDG LTD 1.6%
Value $200M Shares 926,700 Share Price $215.70 Est. Cost/Share — Unrealized @ Report Date —
PANW PALO ALTO NETWORKS INC 1.6%
Value $196M Shares 852,105 Share Price $229.67 Est. Cost/Share — Unrealized @ Report Date —
EQIX EQUINIX INC 1.5%
Value $188M Shares 267,597 Share Price $702.30 Est. Cost/Share — Unrealized @ Report Date —
— TIFFANY & CO NEW 1.5%
Value $186M Shares 1,527,698 Share Price $121.94 Est. Cost/Share — Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 1.4%
Value $179M Shares 6,537,500 Share Price $27.45 Est. Cost/Share — Unrealized @ Report Date —
NYT NEW YORK TIMES CO 1.4%
Value $174M Shares 4,137,542 Share Price $42.03 Est. Cost/Share — Unrealized @ Report Date —
GD GENERAL DYNAMICS CORP 1.4%
Value $172M Shares 1,151,481 Share Price $149.46 Est. Cost/Share — Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 1.3%
Value $169M Shares 1,140,000 Share Price $147.90 Est. Cost/Share — Unrealized @ Report Date —
— BRISTOL-MYERS SQUIBB CO 1.3%
Value $158M Shares 44,200,000 Share Price $3.58 Est. Cost/Share — Unrealized @ Report Date —
BX BLACKSTONE GROUP INC 1.3%
Value $157M Shares 2,768,319 Share Price $56.66 Est. Cost/Share — Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 1.2%
Value $156M Shares 1,050,000 Share Price $148.11 Est. Cost/Share — Unrealized @ Report Date —
— QIAGEN NV 1.0%
Value $123M Shares 2,881,000 Share Price $42.81 Est. Cost/Share — Unrealized @ Report Date —
— WRIGHT MED GROUP N V 1.0%
Value $122M Shares 4,100,000 Share Price $29.72 Est. Cost/Share — Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 1.0%
Value $120M Shares 3,500,000 Share Price $34.31 Est. Cost/Share — Unrealized @ Report Date —
— PLAYA HOTELS & RESORTS NV 0.9%
Value $111M Shares 30,606,930 Share Price $3.62 Est. Cost/Share — Unrealized @ Report Date —
TRU TRANSUNION 0.8%
Value $104M Shares 1,192,747 Share Price $87.04 Est. Cost/Share — Unrealized @ Report Date —
— CAESARS ENTMT CORP 0.8%
Value $97.22M Shares 8,015,000 Share Price $12.13 Est. Cost/Share — Unrealized @ Report Date —
CI CIGNA CORP NEW 0.8%
Value $93.83M Shares 500,000 Share Price $187.65 Est. Cost/Share — Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 0.7%
Value $87.87M Shares 1,750,000 Share Price $50.21 Est. Cost/Share — Unrealized @ Report Date —
— MYOKARDIA INC 0.7%
Value $84.54M Shares 875,000 Share Price $96.62 Est. Cost/Share — Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 0.7%
Value $84.18M Shares 525,000 Share Price $160.34 Est. Cost/Share — Unrealized @ Report Date —
— NEW ORIENTAL ED & TECHNOLOGY 0.7%
Value $82.17M Shares 631,000 Share Price $130.23 Est. Cost/Share — Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 0.6%
Value $74.21M Shares 650,000 Share Price $114.17 Est. Cost/Share — Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.6%
Value $73.48M Shares 2,250,000 Share Price $32.66 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.5%
Value $67.9M Shares 7,170,213 Share Price $9.47 Est. Cost/Share — Unrealized @ Report Date —
AGIO AGIOS PHARMACEUTICALS INC 0.5%
Value $66.85M Shares 1,250,000 Share Price $53.48 Est. Cost/Share — Unrealized @ Report Date —
— FIBROGEN INC 0.5%
Value $65.86M Shares 1,625,000 Share Price $40.53 Est. Cost/Share — Unrealized @ Report Date —
— MOMO INC 0.5%
Value $64.16M Shares 81,601,000 Share Price $0.79 Est. Cost/Share — Unrealized @ Report Date —
— KARUNA THERAPEUTICS INC 0.5%
Value $64.09M Shares 575,000 Share Price $111.46 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.5%
Value $61.45M Shares 61,438,000 Share Price $1.00 Est. Cost/Share — Unrealized @ Report Date —
GRFS GRIFOLS S A 0.5%
Value $56.78M Shares 3,113,222 Share Price $18.24 Est. Cost/Share — Unrealized @ Report Date —
— ARENA PHARMACEUTICALS INC 0.5%
Value $56.66M Shares 900,000 Share Price $62.95 Est. Cost/Share — Unrealized @ Report Date —
— ZOGENIX INC 0.4%
Value $54.02M Shares 2,000,000 Share Price $27.01 Est. Cost/Share — Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.4%
Value $50.29M Shares 35,102,000 Share Price $1.43 Est. Cost/Share — Unrealized @ Report Date —
ZNTL ZENTALIS PHARMACEUTICALS INC 0.4%
Value $47.6M Shares 991,174 Share Price $48.02 Est. Cost/Share — Unrealized @ Report Date —
— GENERATION BIO CO 0.4%
Value $44.49M Shares 2,118,819 Share Price $21.00 Est. Cost/Share — Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.4%
Value $44.15M Shares 2,500,000 Share Price $17.66 Est. Cost/Share — Unrealized @ Report Date —
EFX EQUIFAX INC 0.4%
Value $43.89M Shares 255,344 Share Price $171.88 Est. Cost/Share — Unrealized @ Report Date —
— DECIPHERA PHARMACEUTICALS IN 0.3%
Value $42.7M Shares 715,000 Share Price $59.72 Est. Cost/Share — Unrealized @ Report Date —
UTHR UNITED THERAPEUTICS CORP DEL 0.3%
Value $42.35M Shares 350,000 Share Price $121.00 Est. Cost/Share — Unrealized @ Report Date —
— THERAVANCE BIOPHARMA INC 0.3%
Value $40.87M Shares 41,905,000 Share Price $0.98 Est. Cost/Share — Unrealized @ Report Date —
— CARA THERAPEUTICS INC 0.3%
Value $39.33M Shares 2,300,000 Share Price $17.10 Est. Cost/Share — Unrealized @ Report Date —
LNTH LANTHEUS HLDGS INC 0.3%
Value $37.68M Shares 2,634,999 Share Price $14.30 Est. Cost/Share — Unrealized @ Report Date —
CYTK CYTOKINETICS INC 0.3%
Value $35.35M Shares 1,500,000 Share Price $23.57 Est. Cost/Share — Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.3%
Value $35.34M Shares 850,000 Share Price $41.58 Est. Cost/Share — Unrealized @ Report Date —
ARWR ARROWHEAD PHARMACEUTICALS IN 0.3%
Value $34.55M Shares 800,000 Share Price $43.19 Est. Cost/Share — Unrealized @ Report Date —
— PORTOLA PHARMACEUTICALS INC 0.3%
Value $33.19M Shares 1,844,757 Share Price $17.99 Est. Cost/Share — Unrealized @ Report Date —
— IQIYI INC 0.3%
Value $33.1M Shares 29,500,000 Share Price $1.12 Est. Cost/Share — Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 0.2%
Value $31.2M Shares 51,672,000 Share Price $0.60 Est. Cost/Share — Unrealized @ Report Date —
— AMYRIS INC 0.2%
Value $29.93M Shares 7,009,527 Share Price $4.27 Est. Cost/Share — Unrealized @ Report Date —
— HORIZON PHARMA INVT LTD 0.2%
Value $29.37M Shares 15,047,000 Share Price $1.95 Est. Cost/Share — Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.2%
Value $29.22M Shares 1,500,000 Share Price $19.48 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.2%
Value $28.62M Shares 2,100,000 Share Price $13.63 Est. Cost/Share — Unrealized @ Report Date —
— FORESCOUT TECHNOLOGIES INC 0.2%
Value $27.67M Shares 1,305,000 Share Price $21.20 Est. Cost/Share — Unrealized @ Report Date —
PLRX PLIANT THERAPEUTICS INC 0.2%
Value $27.62M Shares 850,801 Share Price $32.46 Est. Cost/Share — Unrealized @ Report Date —
— AVROBIO INC 0.2%
Value $27.48M Shares 1,575,000 Share Price $17.45 Est. Cost/Share — Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.2%
Value $25.29M Shares 1,335,000 Share Price $18.94 Est. Cost/Share — Unrealized @ Report Date —
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 0.2%
Value $25.02M Shares 2,500,000 Share Price $10.01 Est. Cost/Share — Unrealized @ Report Date —
RCUS ARCUS BIOSCIENCES INC 0.2%
Value $24.74M Shares 1,000,000 Share Price $24.74 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.2%
Value $22.65M Shares 2,391,536 Share Price $9.47 Est. Cost/Share — Unrealized @ Report Date —
FXI ISHARES TR 0.2%
Value $22.33M Shares 562,500 Share Price $39.70 Est. Cost/Share — Unrealized @ Report Date —
VCYT VERACYTE INC 0.2%
Value $22.02M Shares 850,000 Share Price $25.90 Est. Cost/Share — Unrealized @ Report Date —
— AMARIN CORP PLC 0.2%
Value $21.63M Shares 3,125,000 Share Price $6.92 Est. Cost/Share — Unrealized @ Report Date —
— GOSSAMER BIO INC 0.2%
Value $20.02M Shares 20,000,000 Share Price $1.00 Est. Cost/Share — Unrealized @ Report Date —
— INVITAE CORP 0.2%
Value $19.89M Shares 656,528 Share Price $30.29 Est. Cost/Share — Unrealized @ Report Date —
— ZYMEWORKS INC 0.2%
Value $19.84M Shares 550,000 Share Price $36.07 Est. Cost/Share — Unrealized @ Report Date —
HWM HOWMET AEROSPACE INC 0.2%
Value $19.01M Shares 1,199,186 Share Price $15.85 Est. Cost/Share — Unrealized @ Report Date —
— INTERCEPT PHARMACEUTICALS IN 0.2%
Value $19M Shares 25,500,000 Share Price $0.75 Est. Cost/Share — Unrealized @ Report Date —
KRYS KRYSTAL BIOTECH INC 0.1%
Value $18.64M Shares 450,000 Share Price $41.42 Est. Cost/Share — Unrealized @ Report Date —
— PRINCIPIA BIOPHARMA INC 0.1%
Value $17.94M Shares 300,000 Share Price $59.79 Est. Cost/Share — Unrealized @ Report Date —
— ZEALAND PHARMA A S 0.1%
Value $17.5M Shares 500,000 Share Price $35.00 Est. Cost/Share — Unrealized @ Report Date —
LQDA LIQUIDIA TECHNOLOGIES INC 0.1%
Value $15.58M Shares 1,850,000 Share Price $8.42 Est. Cost/Share — Unrealized @ Report Date —
— TRICIDA INC 0.1%
Value $13.74M Shares 500,000 Share Price $27.48 Est. Cost/Share — Unrealized @ Report Date —
QURE UNIQURE NV 0.1%
Value $13.52M Shares 300,000 Share Price $45.06 Est. Cost/Share — Unrealized @ Report Date —
RPRX ROYALTY PHARMA PLC 0.1%
Value $13.35M Shares 275,000 Share Price $48.55 Est. Cost/Share — Unrealized @ Report Date —
RC READY CAPITAL CORP 0.1%
Value $11.73M Shares 1,350,226 Share Price $8.69 Est. Cost/Share — Unrealized @ Report Date —
SVRA SAVARA INC 0.1%
Value $11.13M Shares 4,470,964 Share Price $2.49 Est. Cost/Share — Unrealized @ Report Date —
CRSP CRISPR THERAPEUTICS AG 0.1%
Value $11.02M Shares 150,000 Share Price $73.49 Est. Cost/Share — Unrealized @ Report Date —
— CONSTELLATION PHARMCETICLS I 0.1%
Value $10.52M Shares 350,000 Share Price $30.05 Est. Cost/Share — Unrealized @ Report Date —
PACB PACIFIC BIOSCIENCES CALIF IN 0.1%
Value $10.35M Shares 3,000,000 Share Price $3.45 Est. Cost/Share — Unrealized @ Report Date —
AKBA AKEBIA THERAPEUTICS INC 0.1%
Value $10.19M Shares 750,000 Share Price $13.58 Est. Cost/Share — Unrealized @ Report Date —
— ATENTO S A 0.1%
Value $7.712M Shares 11,212,205 Share Price $0.69 Est. Cost/Share — Unrealized @ Report Date —
— AKOUOS INC 0.0%
Value $5.063M Shares 225,000 Share Price $22.50 Est. Cost/Share — Unrealized @ Report Date —
— APPLIED MOLECULAR TRANS INC 0.0%
Value $5.028M Shares 200,000 Share Price $25.14 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.0%
Value $5.009M Shares 6,750,000 Share Price $0.74 Est. Cost/Share — Unrealized @ Report Date —
— INTERCEPT PHARMACEUTICALS IN 0.0%
Value $4.822M Shares 6,500,000 Share Price $0.74 Est. Cost/Share — Unrealized @ Report Date —
— REPARE THERAPEUTICS INC 0.0%
Value $4.653M Shares 150,000 Share Price $31.02 Est. Cost/Share — Unrealized @ Report Date —
— ARYA SCIENCES ACQUISTION CO 0.0%
Value $4.64M Shares 400,000 Share Price $11.60 Est. Cost/Share — Unrealized @ Report Date —
— FUSION PHARMACEUTICALS INC 0.0%
Value $4.368M Shares 250,000 Share Price $17.47 Est. Cost/Share — Unrealized @ Report Date —
— IVERIC BIO INC 0.0%
Value $3.825M Shares 750,000 Share Price $5.10 Est. Cost/Share — Unrealized @ Report Date —
— CTRIP COM INTL LTD 0.0%
Value $3.483M Shares 3,508,000 Share Price $0.99 Est. Cost/Share — Unrealized @ Report Date —
DMTKQ DERMTECH INC 0.0%
Value $2.576M Shares 194,675 Share Price $13.23 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.0%
Value $2.281M Shares 7,174,613 Share Price $0.32 Est. Cost/Share — Unrealized @ Report Date —
RNAM AVIDITY BIOSCIENCES INC 0.0%
Value $1.413M Shares 50,000 Share Price $28.26 Est. Cost/Share — Unrealized @ Report Date —
GOSS GOSSAMER BIO INC 0.0%
Value $1.3M Shares 100,000 Share Price $13.00 Est. Cost/Share — Unrealized @ Report Date —
CTMX CYTOMX THERAPEUTICS INC 0.0%
Value $1.241M Shares 148,952 Share Price $8.33 Est. Cost/Share — Unrealized @ Report Date —
— GOL LINHAS AEREAS INTELIGENT 0.0%
Value $582K Shares 85,838 Share Price $6.78 Est. Cost/Share — Unrealized @ Report Date —